Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q3 2025 Earnings Call Transcript November 3, 2025
Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.72, expectations were $1.63.
Operator: Good afternoon. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to Halozyme’s Third Quarter 2025 Financial and Operating Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I will now...
